Invention Application
- Patent Title: ANTIBODY DRUG CONJUGATES
-
Application No.: US15291024Application Date: 2016-10-11
-
Publication No.: US20170106095A1Publication Date: 2017-04-20
- Inventor: David Bryant BATT , Seth Alexander Ettenberg , Nicole Haubst , Tiancen Hu , David Jenkins , Engin Toksoz , Konstantin Petropoulos , Matthew John Meyer
- Applicant: David Bryant BATT , Seth Alexander Ettenberg , Nicole Haubst , Tiancen Hu , David Jenkins , Engin Toksoz , Konstantin Petropoulos , Matthew John Meyer
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/30 ; A61K31/506 ; C07K16/28 ; A61K45/06
Abstract:
The present invention relates to anti-FGFR2 and FGFR4 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
Information query
